163 related articles for article (PubMed ID: 33603617)
1. The impact of medium dose UVA1 phototherapy on pruritus, DLQI and SCORAD index in patients with atopic dermatitis.
Malinowska K; Woźniacka A; Bogaczewicz J
Postepy Dermatol Alergol; 2020 Dec; 37(6):962-967. PubMed ID: 33603617
[TBL] [Abstract][Full Text] [Related]
2. Medium-dose ultraviolet A1 phototherapy improves SCORAD index and increases mRNA expression of interleukin-4 without direct effect on human β defensin-1, interleukin-10, and interleukin-31.
Bogaczewicz J; Malinowska K; Sysa-Jedrzejowska A; Wozniacka A
Int J Dermatol; 2016 Jul; 55(7):e380-5. PubMed ID: 26748443
[TBL] [Abstract][Full Text] [Related]
3. 'High dose' vs. 'medium dose' UVA1 phototherapy in italian patients with severe atopic dermatitis.
Pacifico A; Iacovelli P; Damiani G; Ferraro C; Cazzaniga S; Conic RRZ; Leone G; Morrone A
J Eur Acad Dermatol Venereol; 2019 Apr; 33(4):718-724. PubMed ID: 30468530
[TBL] [Abstract][Full Text] [Related]
4. Medium-dose UVA1 cold-light phototherapy in the treatment of severe atopic dermatitis.
von Kobyletzki G; Pieck C; Hoffmann K; Freitag M; Altmeyer P
J Am Acad Dermatol; 1999 Dec; 41(6):931-7. PubMed ID: 10570376
[TBL] [Abstract][Full Text] [Related]
5. Medium dose ultraviolet A1 phototherapy and mRNA expression of interleukin 8, interferon γ, and chemokine receptor 4 in acute skin lesions in atopic dermatitis.
Bogaczewicz J; Malinowska K; Sysa-Jedrzejowska A; Wozniacka A
Postepy Dermatol Alergol; 2016 Jun; 33(3):170-5. PubMed ID: 27512350
[TBL] [Abstract][Full Text] [Related]
6. Long-term efficacy of medium-dose UVA1 phototherapy in atopic dermatitis.
Abeck D; Schmidt T; Fesq H; Strom K; Mempel M; Brockow K; Ring J
J Am Acad Dermatol; 2000 Feb; 42(2 Pt 1):254-7. PubMed ID: 10642681
[TBL] [Abstract][Full Text] [Related]
7. Medium-dose ultraviolet A1 phototherapy and mRNA expression of TSLP, TARC, IL-5, and IL-13 in acute skin lesions in atopic dermatitis.
Bogaczewicz J; Malinowska K; Sysa-Jedrzejowska A; Wozniacka A
Int J Dermatol; 2016 Aug; 55(8):856-63. PubMed ID: 26475182
[TBL] [Abstract][Full Text] [Related]
8. [Clinical observation on the efficacy and safety of dupilumab in the treatment of moderate to severe atopic dermatitis].
Li CY; Chen S; Qian WL; Yang L; Zheng Q; Chen AJ; Chen J; Huang K; Fang S; Wang P; Hu L; Liu XR; Zhao XQ; Tan N; Cai T
Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Oct; 57(10):1590-1595. PubMed ID: 37859375
[TBL] [Abstract][Full Text] [Related]
9. High-dose versus medium-dose UVA1 phototherapy for patients with severe generalized atopic dermatitis.
Tzaneva S; Seeber A; Schwaiger M; Hönigsmann H; Tanew A
J Am Acad Dermatol; 2001 Oct; 45(4):503-7. PubMed ID: 11568738
[TBL] [Abstract][Full Text] [Related]
10. Narrowband ultraviolet B phototherapy improves quality of life of psoriasis and atopic dermatitis patients up to 3 months: Results from an observational multicenter study.
Väkevä L; Niemelä S; Lauha M; Pasternack R; Hannuksela-Svahn A; Hjerppe A; Joensuu A; Soronen M; Ylianttila L; Pastila R; Kautiainen H; Snellman E; Grönroos M; Karppinen T
Photodermatol Photoimmunol Photomed; 2019 Sep; 35(5):332-338. PubMed ID: 31063610
[TBL] [Abstract][Full Text] [Related]
11. Association of Inadequately Controlled Disease and Disease Severity With Patient-Reported Disease Burden in Adults With Atopic Dermatitis.
Simpson EL; Guttman-Yassky E; Margolis DJ; Feldman SR; Qureshi A; Hata T; Mastey V; Wei W; Eckert L; Chao J; Arnold RJG; Yu T; Vekeman F; Suárez-Fariñas M; Gadkari A
JAMA Dermatol; 2018 Aug; 154(8):903-912. PubMed ID: 29971354
[TBL] [Abstract][Full Text] [Related]
12. Medium-dose ultraviolet (UV) A1 vs. narrowband UVB phototherapy in atopic eczema: a randomized crossover study.
Gambichler T; Othlinghaus N; Tomi NS; Holland-Letz T; Boms S; Skrygan M; Altmeyer P; Kreuter A
Br J Dermatol; 2009 Mar; 160(3):652-8. PubMed ID: 19120333
[TBL] [Abstract][Full Text] [Related]
13. Phototherapy for atopic eczema.
Musters AH; Mashayekhi S; Harvey J; Axon E; Lax SJ; Flohr C; Drucker AM; Gerbens L; Ferguson J; Ibbotson S; Dawe RS; Garritsen F; Brouwer M; Limpens J; Prescott LE; Boyle RJ; Spuls PI
Cochrane Database Syst Rev; 2021 Oct; 10(10):CD013870. PubMed ID: 34709669
[TBL] [Abstract][Full Text] [Related]
14. Topical tacrolimus vs medium-dose ultraviolet A1 phototherapy in the treatment of atopic dermatitis - a preliminary study in relation to parameters of the epidermal barrier function and high-frequency ultrasonography.
Osmola-Mańkowska A; Polańska A; Silny W; Żaba R; Adamski Z; Dańczak-Pazdrowska A
Eur Rev Med Pharmacol Sci; 2014; 18(24):3927-34. PubMed ID: 25555886
[TBL] [Abstract][Full Text] [Related]
15. Mononuclear cells in atopic dermatitis in vivo: immunomodulation of the cutaneous infiltrate by medium-dose UVA1 phototherapy.
Breuckmann F; von Kobyletzki G; Avermaete A; Pieck C; Kreuter A; Brockmeyer NH; Altmeyer P; Gambichler T
Eur J Med Res; 2002 Jul; 7(7):315-22. PubMed ID: 12176681
[TBL] [Abstract][Full Text] [Related]
16. [UVA1 phototherapy. Pilot study of dose finding in acute exacerbated atopic dermatitis].
Dittmar HC; Pflieger D; Schöpf E; Simon JC
Hautarzt; 2001 May; 52(5):423-7. PubMed ID: 11405161
[TBL] [Abstract][Full Text] [Related]
17. [Phototherapy in severe atopic dermatitis. Comparison between current UVA1 therapy, UVA1 cold light and combined UVA-UVB therapy].
von Kobyletzki G; Freitag M; Herde M; Höxtermann S; Stücker M; Hoffmann K; Altmeyer P
Hautarzt; 1999 Jan; 50(1):27-33. PubMed ID: 10068928
[TBL] [Abstract][Full Text] [Related]
18. The effectiveness of high-dose ultraviolet A-1 phototherapy for acute exacerbation of atopic dermatitis in Asians.
Park JB; Jang JY; Kwon DI; Seong SH; Suh KS; Jang MS
Photodermatol Photoimmunol Photomed; 2020 Jul; 36(4):263-270. PubMed ID: 32141113
[TBL] [Abstract][Full Text] [Related]
19. Phototherapy for atopic dermatitis: Systematic review and network meta-analysis of randomized controlled trials.
Xiao H; Gu X; Huang Y; Zhu W; Shen M
Photodermatol Photoimmunol Photomed; 2022 May; 38(3):233-240. PubMed ID: 34653289
[TBL] [Abstract][Full Text] [Related]
20. Interventions for chronic pruritus of unknown origin.
Andrade A; Kuah CY; Martin-Lopez JE; Chua S; Shpadaruk V; Sanclemente G; Franco JV
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD013128. PubMed ID: 31981369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
